Dublin, Jan. 08, 2025 (GLOBE NEWSWIRE) -- The "Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
Dublin, July 14, 2025 (GLOBE NEWSWIRE) -- The "Methicillin-resistant Staphylococcus Aureus (MRSA) Epidemiology Forecast 2025-2034" report has been added to ResearchAndMarkets.com's offering. Studies ...
The global Methicillin-Resistant Staphylococcus Aureus (MRSA) Treatment Industry has valued at US$ 3.9 billion in 2022 and is anticipated to grow to US$ 5.5 billion by 2030, with sales revenue set to ...
The global Methicillin-Resistant Staphylococcus Aureus (MRSA) Treatment Industry has valued at US$ 3.9 billion in 2022 and is anticipated to grow to US$ 5.5 billion by 2030, with sales revenue set to ...
Drug-resistant infections such as MRSA are widespread among children in Oceania, with major gaps in access and approved ...
In a bid to create a vaccine, scientists from GSK and Trinity have researched Staphylococcus aureus’s process of immune response disruption. New research has revealed a trick used by the bacterium ...
MRSA is a potentially dangerous type of staph bacteria that is resistant to certain antibiotics and may cause skin and other infections. Recent data show that Americans visit the doctor approximately ...
Here is some background information about MRSA. Methicillin-resistant Staphylococcus aureus (MRSA) bacteria are resistant to all beta-lactam antibiotics such as methicillin, penicillin, oxacillin and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results